Ginkgo biloba and Acetazolamide Prophylaxis for Acute Mountain Sickness | Zendy

Tony Chow | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Ginkgo biloba and Acetazolamide Prophylaxis for Acute Mountain Sickness

Author(s) -

Tony Chow

Publication year - 2005

Publication title -

archives of internal medicine

Language(s) - English

Resource type - Journals

eISSN - 1538-3679

pISSN - 0003-9926

DOI - 10.1001/archinte.165.3.296

Subject(s) - ginkgo biloba , acetazolamide , placebo , medicine , ginkgoales , randomized controlled trial , placebo group , anesthesia , confidence interval , pharmacology , chemistry , pharmacognosy , biological activity , biochemistry , alternative medicine , pathology , in vitro

Acute mountain sickness (AMS) commonly occurs when unacclimatized individuals ascend to altitudes above 2000 m. Acetazolamide and Ginkgo biloba have both been recommended for AMS prophylaxis; however, there is conflicting evidence regarding the efficacy of Ginkgo biloba use. We performed a randomized, placebo-controlled trial of acetazolamide vs Ginkgo biloba for AMS prophylaxis.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research